Cancer Patients With Medical Marijuana Cards Less Likely to Receive Excess Antiemetics, Arkansas Study Finds
Comments Off on Cancer Patients With Medical Marijuana Cards Less Likely to Receive Excess Antiemetics, Arkansas Study Finds
April 30, 2026
Compared with non-MMJ cardholders, MMJ cardholders were less likely to experience antiemetic overuse (aOR: 0.76, p < 0.001). Further investigation into the use, effectiveness, and safety of cannabis for CINV mitigation is needed to inform patient and…
Cancer Patients With Medical Marijuana Cards Were Less Likely to Receive Excess Antiemetics, Arkansas Study Finds
Comments Off on Cancer Patients With Medical Marijuana Cards Were Less Likely to Receive Excess Antiemetics, Arkansas Study Finds
April 30, 2026
Compared with non-MMJ cardholders, MMJ cardholders were less likely to experience antiemetic overuse (aOR: 0.76, p < 0.001). Antiemetic overuse was identified in 7.5% of chemotherapy cycles overall.